Updates of Closed-incision Negative Pressure Therapy (CINPT)

Abstract

The idea of negative pressure strategy traces all the way back to the earliest civilizations; during the Roman period, the method of utilizing dom-shapped cupping glasses was utilized to make the pull expected to promote recuperating. This procedure was utilized all through the nineteenth century. In 1821, an English doctor named Dr. Francis Fox imagined the "glass leech" strategy. From that point in 1952, an imaginative methodology was acquainted with the treatment of serious, complex wounds using sub-atmospheric or negative pressure known as "negative pressure wound therapy" (NPWT). Afterward, the "vacuum-assisted closure", or VAC treatment system established by Dr. Louis Argenta in 1990 changed the advanced wound care market, nevertheless the most clinically proven alternative for the treatment of complex, difficult to-heal wounds. These treatments use a foam dressing that is adjusted to the wound bed. Whenever fixed and put under negative (vacuum) pressure, the system establishes a remarkable wound healing environment that has been displayed to advance the wound healing process, decrease oedema, set up the wound bed for closure, promote the development of granulation tissue and remove infectious materials. The negative pressure treatment system tends to addresses personal satisfaction through a simple to-utilize system intended to help surgeons in the management and treatment of comorbid wounds, and open abdomen and other wound complications to assist with accomplishing primary fascial closure. Comorbidities can be defined as a simultaneousness of multiple chronic diseases in a same patient. Closed-incision negative tension treatment (CINPT) has changed the manner by which caregivers treat the most serious, complex wounds or comorbid wounds. Wound healing can be accomplished by the host's innate and adaptive immune mechanisms as in an uninfected simple surgical incision through the skin or by combination of the host's defence mechanisms and therapeutic modalities. It has been affirmed in some clinical investigates that growth factors apply astonishing consequences for wound-healing promotion and skin function restoration with no obvious complications. In this review, we have focusing on the treatment of wound complications secondary to comorbidity by a mix of negative pressure treatment followed by a positive pressure infusion with growth factor concentrates.